What is the prognosis for serous carcinoma?

1 Five-year survival rates for early- and advanced-stage serous carcinomas are 75% and 37%, respectively, compared with 86% (p<0.001) and 54% (p<0.001), respectively, for grade 3 endometrioid carcinomas.

How serious is serous carcinoma?

Uterine papillary serous carcinoma is a serious and often life-threatening disease, and its treatment can be complex.

What is uterine papillary serous carcinoma?

Uterine papillary serous carcinoma, or UPSC, is a rare form of endometrial cancer — cancer of the lining of the uterus. UPSC happens in about 10% of uterine cancer cases. It can spread faster and may be more likely to come back after treatment than other types of uterine cancer, even if doctors catch it early.

Can serous carcinoma be cured?

The most common type of the disease, called endometrioid endometrial carcinoma, is usually diagnosed at an early stage and can often be cured with an operation called a hysterectomy to remove the uterus, sometimes followed by radiation therapy. Uterine serous carcinoma is an aggressive type of endometrial cancer.

What stage is high grade serous carcinoma?

A: Most cases of high grade serous ovarian cancer are diagnosed at an advanced stage (stage 3 or 4) and the disease is widespread.

Can you survive serous carcinoma?

Serous uterine cancers have a high rate of metastasis to the omentum and peritoneal surfaces. Survival rates are only 30% to 50% even when disease is confined to the uterus, and median survival is significantly shorter than that for endometrioid adenocarcinoma.

What is high grade papillary serous carcinoma?

High-grade serous carcinoma (HGSC) is a type of tumour that arises from the serous epithelial layer in the abdominopelvic cavity and is mainly found in the ovary. HGSCs make up the majority of ovarian cancer cases and have the lowest survival rates.

Where does papillary serous carcinoma spread?

Background: Uterine papillary serous carcinoma (UPSC) is a highly malignant form of endometrial cancer with a high propensity for metastases and recurrences even when there is minimal or no myometrial invasion. It usually metastasizes to the pelvis, retroperitoneal lymph nodes, upper abdomen, and peritoneum.